Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia

This study has been completed.
Information provided by:
Oslo University Hospital Identifier:
First received: June 30, 2011
Last updated: July 5, 2011
Last verified: June 2011

The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by Oslo University Hospital:

Biospecimen Retention:   Samples Without DNA


Enrollment: 129
Study Start Date: January 1999
Study Completion Date: June 2011
Primary Completion Date: May 2004 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   20 Years to 43 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Case-control study consisting of 43 women developping preeclampsia and 86 women not developping this disorder. All were of Caucasian origin and were nulliparous.


Inclusion Criteria:

  • caucasian,
  • nulliparous

Exclusion Criteria:

  • preexisting cardiovascular diseases,
  • diabetes,
  • hypertension,
  • inflammatory bowel diseases,
  • serious organ diseases, and
  • development of separate gestational diabetes and/or hypertension.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Oslo University Hospital, Department of Medical Biochemistry Identifier: NCT01388283     History of Changes
Other Study ID Numbers: INMARPE11
Study First Received: June 30, 2011
Last Updated: July 5, 2011
Health Authority: Norway:The Data Inspectorate
Norway: Directorate of Health

Keywords provided by Oslo University Hospital:
prognostic marker

Additional relevant MeSH terms:
Hypertension, Pregnancy-Induced
Pregnancy Complications processed this record on April 17, 2014